EMAIL THIS PAGE TO A FRIEND

Chemical & pharmaceutical bulletin

Cytotoxicity of new 5-phenyl-4,5-dihydro-1,3,4-thiadiazole analogues.


PMID 22041082

Abstract

A series of 5-phenyl-4,5-dihydro-1,3,4-thiadiazoles were synthesized and their cytotoxicity was examined against four human cancer cell lines, e.g. lung cancer (A549), ovarian cancer (SK-OV-3), skin cancer (SK-MEL-2), and colon cancer (HCT15). The title compounds were synthesized by condensation of thiosemicarbazide with substituted benzaldehydes, followed by cyclization with acetic anhydrides in good yields. Most of the compounds exhibited significant suppressive activity against the growth of all of the cancer cell lines. The 4-hydroxy analogue of 5-phenyl-4,5-dihydro-1,3,4-thiadiazole (2h) was most active in the inhibition of growth of the SK-MEL-2 cell line, with an IC(50) value of 4.27 µg/ml; followed by compound 2a (IC(50) 5.16 µg/ml). The compounds 2j, 2h, and 2b, bearing 3-methoxy-4-hydroxy-, 4-hydroxy- and 4-methyl substituents in the C-5 phenyl ring respectively, exhibited the highest activity against the SK-OV-3 (IC(50) 7.35 µg/ml), HCT15 (IC(50) 8.25 µg/ml) and A549 (IC(50) 9.40 µg/ml) cell lines, respectively. A structure-activity relationship study revealed that an optimal electron density on the C-5 phenyl ring of 1,3,4-thiadiazoles is crucial for their cytotoxic activity against the human cancer cell lines used in the present study.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

89050
Thiosemicarbazide, puriss. p.a., 98%
CH5N3S
T33405
Thiosemicarbazide, 99%
CH5N3S